Xilai New Version Veterinary Drug GMP Has Passed Acceptance! Ushering in a New Era of Professional Production Bases!

Release time: 2023-05-24

【Summary Description】

The agricultural and animal husbandry industry is developing rapidly, and food safety has risen to the level of a national strategy. Scientific farming, antibiotic-free farming, and cost reduction with efficiency enhancement have become new trends driving industry development, while also promoting continuous transformation and upgrading in the veterinary pharmaceutical industry.

The new version of Veterinary Drug GMP has been fully implemented since June 1, 2022! It introduces more specific and stringent requirements covering various aspects such as personnel qualifications, product quality control, and production management.

From May 19 to 20, 2023, after two days of inspection and acceptance under the new Veterinary Drug GMP standards, Hunan Xilai Gao Animal Health Products Co., Ltd. successfully passed the assessment with high scores, thus ushering in a new era for Xilai Gao as a specialized R&D and production base for veterinary drugs under the new GMP standards.

The acceptance inspection was conducted jointly by a panel of experts from the Hunan Provincial Department of Agriculture and Rural Affairs and leaders from Zhuzhou City. In accordance with the relevant standards and acceptance regulations of the new version of Veterinary Drug GMP, the panel listened to a report by Huang Guogang, General Manager of Xilai Gao, on the company’s implementation of GMP operations. The expert panel highly praised Xilai Gao’s hardware and software systems. Through on-site questioning, document review, and sample inspection, the panel also assessed the operational procedures and skills of staff members in relevant positions.

After listening to our company’s work report on the implementation of the new veterinary drug GMP, the expert panel conducted a comprehensive, rigorous, and meticulous inspection of the production workshops, quality control department, testing and analysis laboratory, raw and auxiliary material warehouse, hazardous materials warehouse, and finished-product storage facility, among other areas. They also administered on-site operational assessments to personnel involved in production and quality inspection. The expert panel gained a detailed understanding of each production line, every production workshop, every stage of the manufacturing process, as well as the specific details regarding product quality and production control measures.

At the summary meeting on the morning of May 20, experts highly praised our advanced management system, software and hardware equipment, and the professionalism of our staff, and announced that Hunan Xilai Gao Animal Health Products Co., Ltd. has successfully passed the acceptance inspection under the new version of Veterinary Drug GMP.

The successful completion of the new-version Veterinary Drug GMP acceptance inspection signifies that our company has now met the latest national standards—both in production management and quality management. This marks Xilai Gao’s entry into a new realm of veterinary and chemical pharmaceutical preparations. Taking this milestone as our starting point, we will strictly adhere to the requirements of the new-version Veterinary Drug GMP in organizing our production and operations, standardizing and normalizing the daily management of our production and quality systems, and creating even higher-quality products. We are committed to providing customers with satisfactory services and generating greater value for the improvement of animal health! We warmly welcome both new and existing friends to visit, tour, and exchange ideas at Xilai Gao.